JORDEN DAVID EMERSON (CEO, CFO) sold 9.3% of their position (200K shares) of NUO THERAPEUTICS, INC. on the open market
Open‑market sale worth $300.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0001437749-25-036821
DirectorOfficer· CEO, CFO
Since Aug 2018
-200K
Net shares
Net seller
$300.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
200K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−200K
Price / share
$1.50
Trade value
$300K
% of position
9.3%
11/28/2025
2.15M→1.95M
Total
Net shares
−200K
Net value
-$300K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | S · Sale | −200K | $1.50 | $300K | 9.3% | 2.15M | 1.95M |
| Total | −200K | -$300K | ||||||
Derivative Transactions0
No derivative transactions reported